Wordt geladen...
Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis
OBJECTIVE. Glutaminase 1 (Gls1) is the first enzyme in glutaminolysis. The selective Gls1 inhibitor Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) suppresses Th17 development and ameliorates experimental autoimmune encephalomyelitis (EAE). However, whether inhibition of glutami...
Bewaard in:
| Gepubliceerd in: | Arthritis Rheumatol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6817384/ https://ncbi.nlm.nih.gov/pubmed/31233276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41019 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|